KRAS c.493_494delinsGC ;(p.K165A)

Variant ID: 12-25362802-TT-GC

NM_004985.3(KRAS):c.493_494delinsGC;(p.K165A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Hillig, Roman C RC; Sautier, Brice B; Schroeder, Jens J; Moosmayer, Dieter D; Hilpmann, André A; Stegmann, Christian M CM; Werbeck, Nicolas D ND; Briem, Hans H; Boemer, Ulf U; Weiske, Joerg J; Badock, Volker V; Mastouri, Julia J; Petersen, Kirstin K; Siemeister, Gerhard G; Kahmann, Jan D JD; Wegener, Dennis D; Böhnke, Niels N; Eis, Knut K; Graham, Keith K; Wortmann, Lars L; von Nussbaum, Franz F; Bader, Benjamin B
Publication Date: 2019-02-12

Variant appearance in text: KRAS: K165A
PubMed Link: 30683722
Variant Present in the following documents:
  • pnas.1812963116.sapp.pdf
View BVdb publication page



Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.

Oncotarget
Armenia, Joshua J; Fabris, Linda L; Lovat, Francesca F; Berton, Stefania S; Segatto, Ilenia I; D'Andrea, Sara S; Ivan, Cristina C; Cascione, Luciano L; Calin, George A GA; Croce, Carlo M CM; Colombatti, Alfonso A; Vecchione, Andrea A; Belletti, Barbara B; Baldassarre, Gustavo G
Publication Date: 2014-03-15

Variant appearance in text: K-Ras4B: K165A
PubMed Link: 24727437
Variant Present in the following documents:
  • Main text
  • oncotarget-05-1185.pdf
View BVdb publication page